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ABSTRACT 
Experimental studies indicate that culturing chondrocytes on biodegradable polymeric scaffolds 
may yield “engineered” cartilage for the replacement of tissue lost to injury or diseases such as 
osteoarthritis.  A method of estimating the outcome of cell-polymer cultures would aid in the 
design and evaluation of engineered tissue for therapeutic use.  The goals of this project were 
to develop, validate, and apply first-generation mathematical models that describe the kinetics 
of extracellular matrix (ECM) deposition and scaffold degradation in cell-polymer constructs 
cultured in vitro.  The ECM deposition model is based on a product-inhibition mechanism and 
predicts an asymptotic, exponential increase in the concentration of ECM molecules found in 
cartilage, including collagen and glycosaminoglycans (GAG).  The scaffold degradation model 
uses first-order kinetics to describe the hydrolysis of biodegradable polyesters in systems not 
limited by diffusion.  Each model was fit to published data describing the accumulation of GAG 
and collagen, as well as the degradation of poly glycolic acid (PGA) and poly lactic acid (PLA), 
respectively.  As experimental validation, cell-polymer constructs (n = 24) and unseeded 
scaffolds (n = 24) were cultured in vitro, and biochemical assays for GAG and collagen content, 
as well as scaffold mass measurements, were performed at 1, 2, 4, 6, 8, or 10 weeks of culture 
(n = 8 per time point).  The mathematical models demonstrate a moderate to strong goodness 
of fit with the previously published data and our experimental results (R2=0.75-0.99).  These 
models were also combined to predict the temporal evolution of total construct mass with 
reasonable accuracy (30% RMS deviation).  In ongoing work, estimates of biochemical 
composition derived from these models are being proposed to predict the mechanical properties 
and functionality of the constructs.  This modeling scheme may be useful in elucidating more 
specific mechanisms governing ECM accumulation.  Given their potential predictive power, 
these models may also reduce the cost of performing long-term culture experiments.  
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SPECIFIC AIMS 
The objective of this project was to develop methods of estimating the dynamic 
composition of engineered articular cartilage in culture, for the purposes of 
understanding the biological mechanisms governing neotissue deposition and, in the 
future, predicting the mechanical properties of the constructs as a function of culture 
time.  Mathematical models capable of describing the biochemical composition and 
mechanics of these constructs may lend insight into the effects of various culture 
conditions on in vitro tissue formation.  This thesis was directed by three specific aims: 
· Develop first-generation mathematical models of extracellular matrix 
deposition, polymeric scaffold degradation, and total construct mass from 
hypothesized mechanisms of action. 
· Validate the matrix accumulation and scaffold degradation models by fitting to 
published data sets on engineered cartilage constructs and experimental data 
from this study. 
· Apply the matrix accumulation, scaffold degradation, and total mass models 
to data generated in an in vitro culture system.  
 
 
7
Figure 2. Extracellular matrix molecules of 
articular cartilage (Mow and Ratcliffe 1997). 
 
BACKGROUND 
ARTICULAR CARTILAGE ANATOMY & PHYSIOLOGY 
Articular cartilage is a dense, highly hydrated (60-85%) tissue found on the ends of 
bones in the knee, hip, shoulder, and other joints (Fig. 1); it is classified as a hyaline 
cartilage and is distinguished by its smooth, bluish-white, glistening appearance (Mow 
and Ratcliffe 1997).   It provides a low friction surface for joint motion, and along with 
tendons and ligaments, aids in the transfer of load between bones.  Articular cartilage 
also acts as a cushion, absorbing some of the compressive stress associated with 
physiologic movement.  The functionality of articular cartilage is closely related to the 
tissue’s stratified extracellular matrix (ECM) and the properties of the ECM molecules 
(Fig. 2).  Within the tissue is a relatively sparse, nonuniform distribution of chondrocytes 
(Fig. 3, nuclei stained purple) that produce and maintain an ECM rich in structural 
proteins (Fig. 3, acidophilic collagen fibers stained pink) and proteoglycans.   
 
 
 
 
 
The cells in the layer closest to the tissue surface (i.e., tangential layer) are elongated 
along the surface (Fig. 4) and continuously remodel an ECM consisting mostly of 
 
Figure 1. Schematic of a simple synovial joint 
(Dowson and Wright 1981). 
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Figure 3. Tissue section of articular cartilage, 
hematoxylin and eosin stained (Slomianka 
2001). 
Figure 4. Cell morphology in cartilage layers, 
hematoxylin and eosin stained (Slomianka 
2001). 
collagen.  The collagen fibrils in the superficial zone are parallel to the tissue surface, 
and this arrangement provides the tensile strength necessary to maintain the tissue’s 
resistance to shear stresses.  Chondrocytes along the bone-cartilage interface (i.e. 
radial layer) are stacked, with a cuboidal morphology.  In this deep layer, collagen fibrils 
are arranged perpendicular to the tissue surface and penetrate the tide mark between 
cartilage and bone, anchoring the tissue to the underlying bone.  A transitional layer 
corresponding to 40-60% of the tissue thickness consists of randomly oriented collagen 
fibers and a relatively high concentration of proteoglycans with spherical chondrocytes.  
The properties of articular cartilage are due, in part, to the layers of varying matrix 
molecule composition and organization and cell morphology. 
 
 
 
 
 
 
 
The functionality of articular cartilage is also due, in part, to the properties of the matrix 
molecules.  The most common proteoglycans, including aggrecan, decorin, and 
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versican, are assembled with glycosaminoglycans (GAGs), like chondroitin sulfate and 
keratan sulfate, in a bottlebrush configuration (Fig. 2).  It is important to note that these 
GAGs contain electronegative sulphate groups, and are bound to aggrecan (the 
predominant proteoglycan in articular cartilage) in high densities.  High molecular weight 
hyaluronic acid chains provide a backbone for anchoring aggrecan-GAG units and 
localize the high GAG density within the tissue.  Due to Donnan osmotic pressure – the 
pressure required to maintain equilibrium between concentration and electrochemical 
gradients – water and cations are drawn from the synovial fluid into the extracellular 
space.  It is this “swelling pressure” that allows articular cartilage to absorb and 
dissipate compressive stresses. 
The collagen fibers play an important role in determining the properties of cartilage as 
well.  First, the collagen network, composed primarily of collagen types II, IX, and XI, 
provides steric hindrance to the extrusion of large proteoglycans.  Collagen molecules 
are arranged in fibers, and are organized as a network that interferes with the 
movement of large molecules.  Without this constraint, the tissue would behave like a 
sponge, releasing interstitial fluid and proteoglycans as compressive stress is applied.  
In addition, collagen fibers provide the tensile strength needed to endure shear stresses 
imposed under physiologic loading conditions. (Mow and Ratcliffe 1997) 
The extracellular matrix of articular cartilage may be further separated into three zones, 
by distance from the chondrocytes.  A pericellular matrix, approximately 200nm thick, 
consists of a dense shell of proteoglycans, non-collagenous proteins, and glycoproteins 
in direct contact with the cell membrane.  The territorial matrix is marked by a network of 
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unoriented collagen fibers and a lower proteoglycan content than the pericellular matrix.  
Cells interact with the territorial zone via processes that traverse the pericellular matrix.  
The interterritorial matrix, which comprises the bulk of the matrix mass in articular 
cartilage, is characterized by oriented, large diameter collagen fibrils.  (Buschmann 
1992)  The heterogeneous distribution and arrangement of ECM molecules with 
distance from the cells may lend insight to the assembly of matrix constituents and the 
regulation of their synthesis.  
Articular chondrocytes can adapt to changing biomechanical conditions by changing the 
rates and ways in which ECM is remodeled.  It has been shown that cyclic compression 
of cartilage explants and engineered cartilage constructs can differentially stimulate or 
suppress GAG or protein synthesis, depending on the frequency and magnitude of 
applied stress (Gray et al. 1989; Davisson et al. 2001).  Static compression, in contrast, 
generally suppresses synthesis of proteoglycans and protein (Gray et al. 1988; Gray et 
al. 1989; Ragan et al. 2000).  In addition, chondrocytes exhibit a similar rapid 
biosynthetic response to changes in pH and osmolarity of the interstitial fluid; it is 
thought that these changes in pH and osmolarity are related to the tissue’s fixed charge 
density (FCD) and water content, which may be altered during loading of cartilage 
explants or constructs (Gray et al. 1988; Urban et al. 1993).  As a compressive load is 
applied to the tissue, ECM molecules are compacted and interstitial fluid is driven to 
regions of lower pressure.  This compaction of the ECM brings charged groups on the 
proteoglycans and collagen fibrils closer together, resulting in a local increase in the 
fixed charge density.  Since pH and osmolarity are sensitive to fluctuations in electro- 
and chemical gradients, the local increase in fixed charge density influences local pH 
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and osmolarity, which in turn, may trigger a biosynthetic response through cell-surface 
ion channels, changes in cell volume, or an unknown mechanism.  The relationships 
between fixed charge density, physicochemical parameters, and chondrocytic 
biosynthetic behavior are unclear, and require further investigation.  
CARTILAGE PATHOLOGY 
Cartilage is damaged through trauma, resulting in focal defects or disease, in which 
osteo- or rheumatoid arthritis leads to global joint degeneration (Mow and Ratcliffe 
1997).    Focal defects may be manifested as tears or punctures in the surface of the 
tissue, which result in disruptions of the otherwise continuous and smooth cartilage-
cartilage joint interface.  Such injury can lead to the onset of arthritic diseases as well.  
Osteoarthritis, most often diagnosed in older patients, similarly interferes with normal 
joint motion via increased joint surface roughness.  The quantity of proteoglycans (and 
thus water), retained within cartilage has been shown to decrease with age, and the 
resultant increasing friction between joint surfaces leads to mechanical degradation of 
the cartilage; ultimately, arthritis is an adverse response to interactions between 
changing mechanical and degrading biochemical conditions within the joint.  In addition, 
the normal wound repair responses – closure, scarring, remodeling – common to many 
tissues are highly attenuated in articular cartilage because the tissue lacks sufficient 
blood supply and cell population density for rapid matrix biosynthesis and motile activity.  
The biological limitations   of the tissue permit perpetual joint degeneration from 
traumatic injury and diseases such as osteoarthritis. 
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Both injury and disease lead to some loss of joint function and are typically 
accompanied by pain; the most common clinical interventions include pharmaceuticals 
(analgesics), physical therapy, and corrective surgery.  Analgesics relieve pain at the 
injury or disease site, and can restore some joint function (Pavelka 2000).  Physical 
therapy has been shown to relieve pain and restore some function of osteoarthritis 
patients (Fransen et al. 1997).  When a patient’s joint has degenerated to the point of 
low- or immobility, a total joint replacement may be performed.  In the case of a total 
knee replacement, the femoral chondyle and tibial head are shaved from the ends of the 
bones, exposing the medullary cavity of each bone.  A prosthetic joint, made of titanium 
and ultra-high molecular weight polyethylene, is pressure-fit into the cavities of the 
bones and may be further fixed with bone cement.  Contemporary joint replacements 
provide the patient with several years of use and approximately natural range of motion 
and functionality.  The limitations of prosthetic joints, however, are a relatively short 
service life (~10 years), adverse redistribution of stress on the bones (which can lead to 
bone resorption), and lack of an adaptive response to changing biomechanical stimuli.   
Newer approaches to repairing damaged cartilage include treating focal defects with 
autologous tissue or cells.  Fragments of cartilage are harvested from the perimeter of 
the joint and surgically fixed in the defect; alternatively, chondrocytes may be isolated 
from the autologous tissue and implanted in the wound site (Hunziker 1999).  These 
techniques are intended to restore the structure of the joint surface and underlying 
tissue by filling the defect space with viable tissue or a population of cells capable of 
producing new matrix.  The reported short- and long-term results of these approaches 
are mixed, and donor site availability and morbidity may be limiting factors.  The primary 
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benefit of biologic devices for cartilage repair is the potential for retaining the native 
tissue’s adaptability to changing biomechanical conditions.  The preservation of tissue 
remodeling mechanisms may yield a permanent repair of damaged tissue.  
There is a clear need for tissue replacement therapies capable of restoring the structure 
and function of articulating joint surfaces while retaining the native tissue’s adaptation 
mechanisms.  The methods of clinically treating cartilage damage have historically 
focused on pain management, physical rehabilitation, or implantation of synthetic 
prosthetics.  Biologic devices – including autologous tissue or cells – have emerged 
within the last five years as viable alternatives to traditional joint replacement 
techniques, and may offer the benefits of a longer service life and the ability to respond 
to changing mechanical forces. 
ENGINEERED CARTILAGE 
The field of research known as “tissue engineering” is a broad interdisciplinary approach 
to the design, construction, and evaluation of biological tissue replacement therapies 
(Langer and Vacanti 1993).  It combines the study of cell biology, mechanics, and 
transport phenomena with the development of devices that generate new tissue through 
inductive or conductive mechanisms (Lanza et al. 1997; Glowacki 2001).  Devices for 
cartilage repair, for example, may be entirely cell-based, in which a population of 
differentiated cartilage cells – chondrocytes – are grown ex vivo and implanted at the 
defect site; presumably, these cells will produce and remodel new cartilaginous tissue 
and eventually restore joint function.  Another approach is entirely biomaterial-based, in 
which a biodegradable material is used as a temporary prosthetic and scaffold for 
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infiltration by cells in the surrounding healthy tissue (Solchaga et al. 2000; Gastel et al. 
2001).  Alternatively, cells may be used in conjunction with a biomaterial to increase the 
rate of new tissue formation; in this case the biomaterial acts as a scaffold for new 
tissue formation from the implanted cells and from native cells at the periphery of the 
defect site.  Growth factors, like bone morphogenetic protein (BMP), transforming 
growth factor beta (TGF-b), basic fibroblast growth factor (bFGF), and insulin-like 
growth factor (IGF) have been shown to influence extracellular matrix production in 
chondrocytes (Sah et al. 1994; Sah et al. 1996; Arevalo-Silva et al. 2001; van den Berg 
et al. 2001).  These and other growth factors may be delivered to the damaged tissue 
directly, within a degradable carrier, or from cells genetically engineered to express the 
growth factors, and may stimulate healthy cells to repair a joint defect (Hidaka et al. 
2001).  The roles of cells, scaffolds, and growth factors, as well as the interactions 
among them, in the formation of functional tissue are investigated in tissue engineering 
research.  
The relatively simple structure and avascular, anueral physiology of articular cartilage 
make this tissue a good candidate for development as an “engineered” tissue.  Some 
documented methods of engineering cartilage include seeding hydrogels, like alginate 
and agarose, or other polymeric scaffolds made of poly-lactic acid (PLA), poly-glycolic 
acid (PGA), or collagen with chondrocytes (Buschmann et al. 1992; Freed et al. 1993; 
Mooney et al. 1996; Ragan et al. 2000; Lee et al. 2001).  Construct culture conditions 
can be static, in which media has no bulk flow, or dynamic, in which media flows 
through the constructs as in roller bottles, spinner flasks, or mixed plate type bioreactors 
(Freed et al. 1993; Freed et al. 1994; Freed et al. 1994; Freed et al. 1998).  The scaffold 
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materials are biocompatible and degradable, and provide temporary mechanical support 
and favorable substrate chemistry as cells manufacture and deposit neotissue (Freed et 
al. 1994).  In addition, these scaffolds may be shaped to guide the formation of 
anatomically correct tissue (Cao et al. 1997; Kim and Mooney 1998).  Some challenges 
in finding a suitable scaffold include optimizing the degradation kinetics and ensuring 
that the cells of interest retain their phenotype upon adhesion to the scaffold surface.  In 
addition, matching the material properties and shape of the scaffold with those of the 
native tissue to be replaced is an important clinical consideration. 
Given that one goal of tissue engineers is to develop biological devices capable of 
restoring native tissue structure and function, it is clear that methods of predicting and 
evaluating the performance and behavior of these devices would be useful (Langer and 
Vacanti 1993).  Though much empirical data has been reported for devices cultured in 
vivo and in vitro, a mechanistic approach to interpreting and modeling such data is 
necessary for its proper use in the rational design of future tissue engineered devices.  
Galban and Locke have proposed several models to describe cell growth in engineered 
scaffolds, and these models are based on fundamental equations of mass transfer 
(Galban and Locke 1999; Galban and Locke 1999; Galban and Locke 2000).  With 
respect to the problem of modeling matrix synthesis in a cartilage repair device, one 
phenomenological model has been proposed (Gray et al. 1989), and one mechanistic 
model based on mass transport of oxygen to chondrocytes has been proposed 
(Obradovic et al. 2000).  In reporting the latter model, which is most relevant to this 
work, Obradovic et al. hypothesized that regulation of GAG synthesis is governed by 
oxygen delivery to cells and can be described by equations of mass transfer.  The 
 
 
16
model predicts that as new tissue is formed, permeability of the construct drops and 
oxygen becomes less available to the cells. The model accounts for spatial variations in 
oxygen concentration within a cell-scaffold construct (due to local differences in 
permeability and diffusivity) and can estimate the temporal changes in quantity and 
location of GAGs within a construct.  There are, to my knowledge, no published 
mechanistic models of collagen deposition or total construct mass for developing 
engineered cartilage. 
The aim of this study is to develop mathematical models describing accumulation of the 
two major extracellular matrix constituents of articular cartilage – GAG and collagen – 
and the degradation of a polymeric scaffold in an engineered tissue construct.  The 
models are based on general, hypothesized mechanisms governing these processes, 
which for this study are assumed to be independent, and the models are intended to 
guide future studies of the biophysics of cell metabolism and cell-matrix interactions.  
Elucidating the mechanisms underlying matrix biosynthesis and reliably estimating 
scaffold degradation kinetics through the use of these models may contribute to the 
design and optimization of engineered cartilage and other tissues.  In addition, a model 
based on these accumulation and degradation models is proposed for predicting the 
total construct mass as a function of time.  This modeling regime may, in the future, may 
be applied with known structure-property relationships to estimate the mechanical 
properties of maturing engineered cartilage constructs. 
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BIOLOGY AND MATHEMATICAL MODELING 
Mathematical models are increasingly used to investigate the behavior and mechanisms 
of chemical, mechanical, and electrical phenomena observed in biological systems.  For 
example, blood circulation, control of cell volume, muscle mechanics, nueral systems, 
population dynamics, and genetics are now rigorously studied through the development 
and application of mathematical models (Marsden et al. 2002).   
Models are used to describe patterns in the observed data, and may be empirically 
derived (a.k.a. phenomenological modeling) or based on known mechanisms and 
derived from fundamental equations.  In general, empirical models are designed to 
describe and predict the observed data well, and may consist of complex interactions 
between dependent and independent variables with little or no physical significance.  In 
contrast, mechanistic models are intended to describe the processes governing 
observed phenomena with known and definable physical relationships between 
parameters.  In engineering and other applications where “what” happens is more 
important than “how” it happens, empirical models are often adequate; for example, 
heat and mass transfer properties of non-biological systems are routinely calculated 
from empirical relationships (Incropera and Dewitt 1996).  When studying and 
characterizing biological systems, however, a mechanistic description of events is often 
more useful than empirical descriptors. 
As described above, there are few published models, empirical or mechanistic, for 
describing the macroscopic structural and functional properties of tissue constructs.  
Mathematical models may be beneficial to future investigations by providing information 
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about the long-term fate of the constructs and the biological mechanisms regulating 
construct development.  This work focuses on the development of first-generation 
mathematical models, with mechanistic underpinnings, capable of describing construct 
composition as a function of in vitro culture time.  In future work, these models may be 
adapted to incorporate the influences of more parameters and combined with empirical 
and mechanistic structure-property relationships to estimate construct mechanical 
properties. 
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Figure 5. GAG concentration (n, right axis) and synthesis rate (¡, left 
axis) as a function of culture time (Buschmann et al. 1992). Data 
reported as mean ± standard deviation (s.d.) (n=10—12). 
 
METHODS 
MODEL FORMULATION – MATRIX ACCUMULATION 
A typical data set generated in a study of engineered cartilage (Buschmann et al. 1992) 
shows that as the construct GAG concentration increases with time, the GAG synthesis 
rate drops (Fig. 5).  This response is also observed in chondrocytes in monolayer fed 
exogenous proteoglycans (Fig. 6) (Handley and Lowther 1977). 
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Figure 7. GAG synthesis rate vs. concentration. 
The GAG synthesis rate data were determined by measuring the incorporation of 
radiolabeled sulfate or acetate.  Using Buschmann’s data, a strong negative correlation 
(r2 = 0.82) was found between concentration and synthesis rate (Fig. 7).  Chondrocyte 
monolayers have also been shown to respond to exogenous proteoglycans in an 
analogous, dose-dependent manner (Fig. 8) (Handley and Lowther 1977). 
 
 
 
 
 
 
 
 
 
 
The negative correlation between synthesis rate and concentration of proteoglycan 
suggests that the accumulation of GAG is governed by a negative feedback, or product 
inhibition, loop.  In other words, there is a “target” or steady-state concentration of each 
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Figure 9. Chondrocyte-PGA construct after 12 days 
of in vitro culture in a bioreactor (Freed et al. 1998). 
Safranin-O (red) stains sulfated GAGs. 
matrix molecule that chondrocytes seek to maintain; as the concentration of each matrix 
component approaches the target concentration, the cells stop accumulating matrix by 
reducing synthesis and/or increasing turnover.  Once the target concentration is 
reached, the cells balance synthesis and turnover, continuously remodeling the ECM.  
The idea of chondrocyte GAG synthesis regulation via GAG concentration in the matrix 
is not new; the mechanisms and biochemical mediators governing chondrocytes 
metabolism have been investigated since the 1970’s (Handley and Lowther 1977; 
Sandy et al. 1980; Hascall et al. 1983; Boyle et al. 1995; Knudson et al. 2000).     
In vivo, chondrocytes deposit matrix molecules in the pericellular space and rely on 
diffusion and fluid convection via the physiologic pump for transport of matrix molecules 
into the interterritorial space, where aggregation and polymerization occurs.  During 
static in vitro culture of engineered constructs, diffusion may be limited by the scaffold 
material and convective forces may be absent altogether.  As a result, the matrix 
molecules accumulate in the pericellular spaces and interterritiorial regions where 
diffusion is greatest, including peripheral regions of the construct (Fig. 9).   
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GAG and collagen molecules, when densely packed around a cell, provide a 
mechanically competent native tissue-like housing capable of changing pericellular 
osmolarity, permeability, and pH (Wilkins et al. 2000).  These local physicochemical 
changes, which gradually occur with matrix molecule accumulation, may control cell 
metabolism by interfering with nutrient uptake and waste withdrawal, adjusting cell 
volume, or changing ion channel activity (Gray et al. 1988; Wilkins et al. 2000).  
Chondrocytes have also been shown to alter their biosynthetic activity in response to 
static and dynamic compression and hydrostatic pressure, in both engineered 
constructs and explants (Kim et al. 1994; Buschmann et al. 1996; Smith et al. 1996; 
Quinn et al. 1998).  The mechanisms of this apparent mechanotransductive response 
are unclear, and may involve deformation of the cell membrane or nucleus, generation 
of streaming potentials, or compaction of the deposited matrix.  Another potential 
negative feedback mechanism is based on a model of cell adhesion.  Chondrocytes 
express adhesion proteins, known as integrins, on their cell surface and can form focal 
adhesions with extracellular matrix proteins like collagen.  Integrins not only serve as 
anchors, however, since many have been associated with intracellular signaling 
pathways that govern cell phenotype and function (Qi and Scully 2000).  Chondrocytes 
also express a hyaluronate-binding surface protein, CD44, which anchors the cells to 
proteoglycans in the pericellular spaces (Knudson and Knudson 1991).  Such surface 
receptors and integrins, when binding with locally accumulated matrix molecules, may 
be a way for chondrocytes to “sense” the location and quantity of GAG and collagen.  
Through surface protein binding and subsequent signaling cascades, production of 
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matrix molecules may be down regulated in response to accumulation in the pericellular 
space. 
Given the complexity of the system to be modeled, the first-generation matrix 
accumulation model is based on product-inhibition.  The definition of product-inhibition, 
as adapted from The Compendium of Chemical Terminology, is the following: 
 A metabolic control mechanism in which the end product of a biochemical 
sequence is able to inhibit the rate of a process early in the sequence, 
thereby controlling the metabolic flux through this pathway (McNaught and 
Wilkinson 1997). 
This hypothesized relationship is stated mathematically: 
(1)    ][][
][
ECMECM
dt
ECMd
SS -µ  
The rate of net synthesis of a matrix molecule, 
dt
ECMd ][
, is proportional to the 
difference between a steady state (“SS”) concentration of that molecule ([ECM]SS) and 
its current concentration.  A rate constant, k, is substituted to form an equation, 
(2)    ]}[]{[
][
ECMECMk
dt
ECMd
SS -=  
which upon rearrangement and integration, 
(3)    òò =- dtkECMECM
ECMd
SS ][][
][
 
yields the following first-order model equation for matrix molecule accumulation: 
(4)    )1(][)]([ ktSS eECMtECM
--=  
Once k is substituted with one over a characteristic time constant, t, the final model 
equation is: 
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Figure 10. Effect of changing the time constant.  
t1 (—) < t2 (—) < t3 (—) 
(5)    )1(][)]([ t
t
SS eECMtECM
-
-=  
where [ECM]SS and t are adjustable parameters and may be dependent on system 
factors including cell type and seeding density, the presence of growth factors, scaffold 
geometry and chemistry, and culture conditions (static vs. dynamic).  In fitting this model 
to data on the biochemical composition of cell-scaffold constructs, least squares 
estimates of [ECM]SS and t were found by non-linear regression.  Each matrix 
component is assumed to accumulate independent of the other; this is an important 
assumption that needs to be validated in the future.  
The form of the accumulation model describes an asymptotic exponential increase in 
matrix molecule concentration with time.   
 
 
 
 
 
In Fig. 10, [ECM]SS is held constant for changing t, and Fig. 11 illustrates constant t 
with changing [ECM]SS:.  At t = t, approximately 63% of the steady state matrix 
molecule concentration has accumulated in the system.  The time constant is large in 
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Figure 11. Effect of changing the steady-state matrix 
molecule concentrations.  
[ECM]SS1 (—) < [ECM]SS2 (—) < [ECM]SS3 (—) 
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systems that produce ECM slowly, and the steady state matrix molecule concentration 
is largest for culture systems that yield the most matrix. 
MODEL FORMULATION – SCAFFOLD DEGRADATION 
There is a variety of scaffold materials being investigated for use in engineered tissues 
(Grande et al. 1997; Ishaug-Riley et al. 1998; Hutmacher 2000).  Hydrogels and poly(a-
hydroxy esters) are some of the most rigorously researched polymers since they exhibit 
long-term biocompatibility, are non-toxic, and have degradation kinetics that can be 
tailored to compliment neotissue growth kinetics (Hakkarainen et al. 1996).  
For the purposes of this study, the scaffold degradation model was designed to describe 
the behavior of the poly(a-hydroxy esters).  Poly-glycolic acid, poly-lactic acid, and their 
copolymers have been shown to support chondrocyte attachment and neotissue 
formation in vitro and in in vivo implantation experiments (Laitinen et al. 1993; Freed et 
al. 1994; Puelacher et al. 1994; Puelacher et al. 1994; Grande et al. 1997).  These 
polymers undergo hydrolysis in which chain scission occurs at the ester bond, releasing 
monomers of glycolic or lactic acid (Hakkarainen et al. 1996).  Under conditions in which 
diffusion is not greatly limited by scaffold geometry, porosity, or culture conditions, the 
rate of monomer release (and thus mass loss) is proportional to the amount of scaffold 
material remaining (Fig. 12) (Rodriguez 1996).   
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Figure 12. Degradation profile for a highly porous PGA scaffold (Freed et al. 
1994).  Data reported as mean ± s.d.. 
 
 
 
 
 
 
In this way, the scaffold degradation obeys first-order decay kinetics: 
(6)    ][
][
Scaffold
dt
Scaffoldd
µ  
Again, a rate constant, k, converts the relationship to an equation: 
(7)    ][
][
Scaffoldk
dt
Scaffoldd
=  
which upon rearrangement and integration, 
(8)    ò ò= dtkScaffold
Scaffoldd
][
][
 
yields the following first-order model equation: 
(9)    kteScaffoldtScaffold -= 0][)]([  
Again, k is replaced by t1 for the final model equation: 
(10)    t
t
eScaffoldtScaffold
-
= 0][)]([  
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Figure 13. Effect of changing the degradation time 
constant. t1 (—) < t2 (—) < t3 (—) 
 
The initial scaffold mass, [Scaffold]0, is known, leaving t as the only adjustable 
parameter in this model.  The effects of adjusting t are illustrated in Fig. 13; a larger 
time constant indicates a longer degradation time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The model estimates that at t = t, 63% of the initial scaffold mass has been lost through 
degradation.  An important assumption is that degradation is independent of neotissue 
formation and cell activity.  It is also significant that this model is dej-243uce 
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Figure 14. Competing processes of scaffold degradation and ECM accumulation (Freed et al. 1998): 
mean scaffold mass (p); mean type II collagen (²) content; mean GAG () content.  
its place.  In order to assess the maturity of an engineered construct, it may be useful to 
model the total mass as a function of culture time. 
 
 
 
 
 
 
 
Given the previously described assumption of independence between degradation and 
accumulation, a preliminary approach to modeling the total construct mass is the simple 
addition of the scaffold degradation and matrix accumulation models.  This approach is 
thus hypothesized to be capable of describing the total construct mass as a function of 
time, where construct mass, M(t) is given as: 
(11)    M(t) =  cell mass + )1(][ GAG
t
SS eGAG
t
-
-  
     + )1(][ Collagen
t
SS eCollagen
t
-
-  
     + Scaffold
t
eScaffold t
-
0][  
Important assumptions for this model include: 1) cell mass is constant, and 2) matrix 
accumulation and scaffold degradation are mutually independent processes.  
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Figure 15. Effect of differing degradation and accumulation time 
constants on estimated construct mass: tscaffold = 2×tmatrix  (—);  
tscaffold = tmatrix (—);tscaffold = 0.5×tmatrix (—). 
 
Mathematically, the behavior of the total construct mass is governed by the competing 
degradation and accumulation models.  For the purposes of engineering tissue 
replacements, it may be optimal for the scaffold degradation and matrix accumulation 
kinetics to be similar, leading to a near-constant scaffold mass with time.  The behavior 
for different combinations of degradation and accumulation time constants can lead to 
rapid accumulation, rapid loss, or approximately steady-state mass conditions (Fig. 15).  
In both cases where the time constants are not equal, however, the model predicts an 
asymptotic approach to the initial construct mass at long times. 
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FITTING THE MODELS 
Data on matrix accumulation and scaffold degradation were gathered from previously 
published reports on engineered cartilage and typical scaffold materials.  In most cases, 
image analysis software (Adobe Photoshop 5) was required to take average and 
standard deviation values from charts; in some cases, the data were obtained from 
tables.  The accumulation and degradation models were fit to average data for each 
culture time by finding least squares estimates of the time constants (tCollagen, tGAG, 
tScaffold) and steady-state matrix molecule concentrations ([Collagen]SS, [GAG]SS) via an 
unweighted quasi-Newton convergence method with Microsoft Excel spreadsheet 
software (initial conditions: t = 1, [ECM]SS = 1).  More specifically, the “Solver” analysis 
tool in Excel allowed the root mean square (RMS) deviation to be minimized by 
adjusting the relevant adjustable parameters (t and [ECM]SS for accumulation, t for 
degradation) as described above.  The quasi-Newton minimization algorithm iteratively 
calculates RMS deviation as it changes the values of the adjustable parameters.  
Depending on the magnitude and sign of the difference in RMS deviation between 
iterations, the algorithm increases or decreases each of the adjustable parameters (two 
adjustable parameters for matrix accumulation, one for scaffold degradation until the 
RMS deviation is minimized.  The quasi-Newton algorithm is considered a fast and 
reliable method of regressing up to as many as 100 parameters (Seber and Wild 1989).  
Strength of model fit was assessed via the coefficient of determination (R2) and percent 
root mean square deviation (RMS deviation divided by the average value of the data).  
Fits were considered strong with R2 ³ 0.80, and RMS deviation <50% were considered 
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reasonably accurate.  For post-hoc tests of multiple comparisons, p < 0.05 were 
considered statistically significant. 
EXPERIMENTAL METHODS 
A two-week pilot study was performed to evaluate the expected variance in GAG and 
collagen mass measurements and reveal any difficulties with the experimental 
protocols.  A total of 15 scaffolds (n = 5 at 4, 7, and 16 days of culture) were seeded 
with ~2.5 million chondrocytes and cultured in 6-well polystyrene culture plates with 
standard complete media.  Increases in GAG and collagen content with culture time 
were observed and confirmed that our culture system behaves similarly to previously 
published culture systems.  The pilot work revealed some difficulties in seeding the 
constructs, and it was determined that prewetting the scaffolds and seeding under 
dynamic conditions (on a horizontal shaker), rather than statically, would improve cell 
attachment and seeding efficiency.  Initial cell counts and data from a DNA assay 
indicate that seeding efficiency ~85% was achieved with this method. 
Variance data on the GAG and collagen contents from the pilot work were used to 
perform a sample size calculation for the main experiment.  The SAS 8.0 package with 
the “UnifyPow” macro (O'Brien 1998) was used to find a minimum sample size that 
would provide enough data to find a significant difference between 6 culture time groups 
with 95% confidence.  The results of this calculation indicated that for an experiment 
with 6 time points, twenty-four samples (four at each time point) would provide enough 
data to detect significance differences at that power.  The main study was designed to 
include culturing twenty-four seeded constructs, with four constructs harvested after 1, 
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2, 4, 6, 8, and 10 weeks of in vitro culture.  In parallel with this experiment, twenty-four 
unseeded (i.e., without cells), but otherwise similar, PGA/PLA constructs were cultured 
in standard complete media to gather data on scaffold degradation kinetics unique to 
this system.  Again, four scaffolds at each culture duration were used.  In all cases, 
scaffolds were randomly assigned to each group. 
Bovine articular chondrocytes were harvested from the femoropatellar and 
glenohumoral grooves of a 2-3 month old calf (A. Arena Brothers, Hopkinton, MA), 
within six hours of slaughter.  On a benchtop sterile field, chips of cartilage were 
carefully excised and placed in a room temperature solution of phosphate buffered 
saline (PBS) treated with antibiotics (penicillin and streptomyocin) and antimycotics 
(amphotercin).  After washing with the PBS solution, the cartilage chips were treated 
with 0.3% collagenase in standard complete media (Ham’s F-12, 10% Fetal Bovine 
Serum, 100 U/mL penicillin, 100 mg/mL streptomycin, and .25mg/mL amphotericin B) 
overnight at 37°C on a horizontal shaker.  The digest solution was then filtered through 
a 180mm nylon filter (Millipore) and the cell suspension was washed three times in the 
PBS solution.  Cell counts were performed using a hemocytometer and viability 
assessed via trypan blue exclusion; the cell suspension was then stored in a 50mL 
polyethylene conical tube in a 37°C incubator until seeding (<48hrs).  Cell viability was 
found to be approximately 95%. 
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Figure 16. Scanning electron micrograph (SEM) 
of PGA fiber bonded with a 5% solution of PLA 
(Kim and Mooney 1998). 
 
 
 
 
 
 
 
Construct scaffolds were made from non-woven poly-glycolic acid (PGA) fleece (Albany 
International Research, Mansfield, MA).  A ½” diameter machinist’s punch was used to 
cut forty-eight circular patches approximately 1mm thick from the fleece (Pazzano et al. 
2000).  The patches were immersed in a 1% w/v poly-l-lactic acid (PLLA) solution in 
methylene chloride for 10s seconds and allowed to dry in a fume hood for at least 10 
minutes.  PLLA is used to bond the PGA fibers, and enhances the stiffness of the 
scaffold (Fig. 16).  The scaffolds were weighed, sterilized with UV light and ethanol for 
30 minutes, and allowed to dry in a dessicator for at least 24 hours prior to seeding.   
For 6 hours prior to seeding with cells, the sterilized scaffolds were prewet with 
complete media and incubated at 37°C in 95% humidity and 5% CO2.  The scaffolds to 
be seeded were then transferred to 15mL conical tubes with a 1mL solution of complete 
media with approximately 2.5 million cells for 12 hours at 37°C on a horizontal shaker.  
Once seeded, the cell-polymer constructs were transferred to 12-well plates for culture 
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Figure 17. Schematic summary of cell isolation and construct 
culture methods.  Adapted from (Freed et al. 1993). 
 
under standard incubation conditions in 3mL media, with media changes every 2-3 days 
(Fig. 17).  Unseeded scaffolds were cultured under identical conditions. 
 
 
 
 
 
 
At the end of the prescribed culture periods, constructs were removed from the plates, 
and laid on three Kimwipes prior to determining the wet weight.  Next, the constructs 
were placed in 15mL conical tubes or 1.5mL cryovials, frozen, and lyophilized.  After 
lyophilization, all constructs were weighed again to find the dry weight, and the cell-
polymer constructs were treated with a 1mL papain (0.125mg/mL) digest solution 
overnight at 60°C.  This digestion liberates extracellular matrix molecules and cells from 
the scaffold and allows for quantitative analysis of the construct biochemistry.  All 
digests were stored at -20°C until use. 
To determine the composition of the constructs, assays for GAG (Farndale et al. 1986), 
hydroxyproline (Woessner 1961), and DNA (Kim et al. 1988) content  were performed.  
To measure the sulphated GAG content, the dimethylmethylene blue 
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spectrophotometric (525nm excitation, 592nm absorbance) method was used.  
Collagen content is correlated to the amount hydroxyproline, an amino acid found with 
known frequency within collagen molecules, in a construct.  The assay includes acid 
hydrolysis of the construct digest, followed by reaction with chloramine-T and para-
dimethylaminobenzaldehyde (pDMAB).  A spectrophotometer (560nm absorbance) is 
used to assess the amount of hydroxyproline is present in the sample, and a 1:10 w/w 
ratio of hydroxyroline to collagen is used to calculate collagen content.  The assays for 
GAG and collagen content were performed in triplicate.  DNA content, an indicator of 
cell number, was measured by Hoechst 33258 dye binding using a fluorometer (358nm 
excitation/458nm absorbance); the DNA assay was performed in duplicate for each 
sample. 
ADDITIONAL STATISTICAL ANALYSIS 
The GAG, collagen, scaffold, and DNA contents were normalized to construct dry 
weight, and Tukey’s post-hoc test for multiple comparisons was used to determine 
statistical differences (p < 0.05 significant) between culture time groups.   
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RESULTS  
The objectives of this work were to 1) develop a first-generation modeling regime for 
describing the composition of engineered cartilage constructs with culture time, 2) 
validate the models by fitting to previously published data and data generated in our 
culture system, and 3) apply the models to our culture system.  Model development was 
described above, and the following shows that the second and third objectives were 
also met.  The matrix accumulation model was validated by fitting to nine published data 
sets on GAG and collagen, as well as data generated in an experiment with our in vitro 
culture system; by both statistical metrics (R
 
 
37
construct dry mass) showed statistically significant differences between most groups 
with culture time, with increasing trends. 
 
 
 
 
 
 
 
 
 
 
ACCUMULATION MODEL VALIDATION 
The matrix accumulation model was fit to nine published data sets from a variety of 
scaffold systems and culture conditions.  These nine data sets represent, to my 
knowledge, all publicly available reports of engineered cartilage with data on the 
temporal accumulation of GAG and/or collagen. Grande et al., studied the effects of 
different scaffold materials and culture conditions (static vs. dynamic) on matrix 
accumulation, but the reported data was limited to three time points, and consequently 
found inadequate for model fitting (Grande et al. 1997).  In general, the model described 
the data for accumulation of two major matrix constituents – GAG and collagen – well 
with coefficients of determination (R2) ranging from 0.77-0.99 and generally low root 
mean square deviations (4.6-37%) (Table 1, Figs. 19 & 20).  The data are reported in 
several different units, though each matrix molecule mass measurement is normalized 
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Figure 18. DNA content with time in culture.  Dashed line 
indicates target DNA content from initial cell seeding 
density. Data reported as mean ± s.d. (n=3-4). 
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to construct volume, mass, or cell count; it is also important to note that quantities of 
GAG and collagen in healthy native tissue are at least an order of magnitude higher 
than those observed in these studies.  The strength of model fits and reasonably high 
accuracies found with these published data sets serve as a preliminary validation of the 
form of the model. 
Table 1. Results of matrix accumulation model fits 
SCAFFOLD  CELL TYPE SOURCE MATRIX 
COMPONENT 
[ECM]SS tECM (DAYS) 
R2 % RMS 
DEV. 
BAC (Buschmann et al. 1992) GAG 17.2 mg/mL 17.1 0.96 6.6 
Agarose Immortalized 
Mouse 
Chondrocytes 
(Mallein-Gerin et al. 
1995) GAG 2.0 mg/mL 24.7 0.77 21.7 
GAG 11.7 %dw  18.6 0.97 5.4 BAC (Vunjak-Novakovic et al. 1996) Collagen 50.4 %dw  131.5 0.98 6.9 
GAG 6.8 %ww 31.3 0.99 5.9 BAC (Freed et al. 1998) 
Collagen II 3.7 %ww 15.9 0.98 6.8 
GAG 1.6 %ww 22.2 0.99 4.6 BAC (Vunjak-Novakovic et 
al. 1998) Collagen 2.4 %ww 16.7 0.98 9 
PGA 
BAC (Stading and Langer 1999) Collagen 3.5 %w w  22.3 0.92 8.1 
GAG 118.3 mg/mg DNA 86.4 0.89 29.0 BAC (Beekman et al. 
1997) Collagen 27.5 mg/mg DNA 17.9 0.77 37.0 Alginate 
BAC (Ragan et al. 2000) Collagen 15.7 mg/mg DNA 22.4 0.89 24.4 
Self-
Assembling 
Peptide 
BAC (Kisiday et al. 2001) GAG 5.9 mg/mL 7.4 0.96 6.1 
GAG 6.1% dw 187 0.95 13.5 
PGA/PLA BAC This study 
Collagen 6.5% dw 18.9 0.80 19.8 
The matrix accumulation behavior observed in this study (Fig. 21) is qualitatively similar 
to that reported by other investigators.  In general, there was less GAG and collagen in 
the constructs than expected, though the synthesized matrix consisted of these 
components in nearly physiologic proportions (~3:1 collagen:GAG).  All constructs were 
free of infection during culture, though one sample from the 8 week seeded group 
became mechanically unstable and disintegrated prior to harvest.  The accumulation 
model was fit to the data for GAG and collagen accumulation with strong goodness of fit 
(R2 = 0.95 and 0.80, respectively) and reasonable accuracy (RMS deviation = 13.5 and 
19.8%, respectively).   
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Figure 19. Best-fit curve for GAG accumulation in an agarose culture system (Buschmann et al. 
1992). Mean ± s.d.. 
 
Figure 18. Best-fit curve for collagen accumulation in an alginate culture system (Ragan et 
al. 2000). Mean ± s.d. 
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Figure 21. GAG (·) and collagen () accumulation from this study, with best-fit curves.  Data 
reported as mean ± s.d., n=3-4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEGRADATION MODEL VALIDATION 
The degradation model was fit to five published data sets for degradation of scaffolds 
with a variety of porosities, and each is based on PGA or PGA/PLA chemistry.  In 
general, the degradation model described the data well with coefficients of 
determination between 0.75 and 0.99, and generally low root mean square deviations 
(4.8-27.5%); the best fits were to data on high porosity scaffolds (Table 2, Fig. 22).  For 
scaffolds of relatively low porosity, the model fits were characterized by lower 
coefficients of determination and higher deviations.  The model also described the 
degradation behavior observed in this study well (R2 = 0.95), though with moderate 
accuracy (25% RMS dev.) (Fig. 23). 
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Figure 22. Best-fit curve for a highly porous PGA scaffold (Freed et al. 1994). Mean 
± s.d. 
Figure 23. Best-fit curve for scaffold degradation in this study. Mean ± s.d., n = 4 
 
Table 2. Results of scaffold degradation model fits 
SCAFFOLD MATERIAL SCAFFOLD POROSITY SOURCE tSCAFFOLD (DAYS) R
2 
% RMS 
DEV 
(Freed et al. 1994) 56.1 0.94 13.8 
PGA 97% 
(Freed et al. 1998) 24.3 0.99 4.8 
PGA/PLA 97% This Study 28.1 0.90 27.3 
92% (Agrawal et al. 2000) 70.0 0.89 10.1 
50:50 PLGA 
73% (Lu et al. 2000) 175.1 0.87 18.8 
75:25 PLGA 0% (Li et al. 1990) 114.6 0.75 27.5 
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Figure 24. Predicted total construct mass (- - -) and measured construct mass 
over culture time. Mean ± s.d., n = 3-4. 
 
ESTIMATING TOTAL CONSTRUCT MASS: APPLICATION OF THE MODELS 
The predictive power of the matrix accumulation and scaffold degradation models was 
evaluated by using them to calculate total construct mass as a function of culture time.  
Construct dry mass measurements in this study are independent of the GAG, collagen, 
and scaffold degradation data, so a comparison of predicted and measured construct 
masses provides some insight to the predictive power of our models.  The total mass 
calculation is an additive combination of the matrix accumulation model (fit to data on 
mass of GAG and collagen), the scaffold degradation model (fit to data on mass of 
scaffold), and a constant cell mass term (determined to be 0.213mg, using 10-11g dry 
mass/chondrocyte).  The calculated values at 7, 14, 28, 42, 56, and 70 days of culture 
were compared with measured values; again R2 and RMS deviation were used as 
metrics for goodness of fit.  In general, the total mass model describes the data well, 
with a coefficient of determination of 0.81 (Fig. 24).  A root mean square deviation of 
31% indicates that the total mass of an engineered tissue construct can be predicted 
with reasonable accuracy using data on GAG, collagen, and scaffold contents. 
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parameters in our models may serve as metrics of construct performance, allowing for 
ready comparison between engineered tissue systems. 
The scaffold degradation model, based on simple hydrolysis, was shown to describe the 
degradation of high porosity ( > 90%) scaffolds well.  The degradation of the polyesters 
PGA and PLA in aqueous media has been shown to occur by hydrolytic chain scission 
of the ester bonds.  During conditions of essentially unlimited diffusion, the rate law for 
this reaction is simply first-order, and is characterized by an exponential decay of the 
mass of the polymer.  This kinetics model was found to be suitable for some PGA and 
PGA/PLA scaffolds, and there appears to be a relationship between model fit and 
scaffold porosity.  Given similar degradation conditions, scaffolds with lower porosity 
have lower coefficients of determination (R2) and higher root mean square deviations 
than those with high porosity (>90%).  The lower porosity scaffolds may interfere with 
the diffusion of water to, and of degradation products away from, some reaction sites; 
this would reduce the rate of scaffold mass loss, especially at early times.  In addition, 
limiting diffusion may alter the degradation profile further by facilitating autocatalysis, 
which occurs when acidic monomers accumulate near reaction sites and catalyze the 
hydrolysis reaction (Li and McCarthy 1999; Lu et al. 2000).  The presented degradation 
model cannot describe the effects of these factors well, and may only be suitable for 
scaffolds with some minimum porosity. 
Applying our models to the problem of predicting total construct mass as a function of 
culture time yielded estimates in fair agreement with the measured values.  The total 
mass model diverged from measured values most significantly at long culture times, but 
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described the general behavior well.  Since the total mass estimates are dominated by 
the scaffold mass, it is difficult to draw any conclusions about the predictive power of the 
accumulation model. 
RELEVANCE TO PUBLISHED MODELS 
The model proposed by Obradovic et al. was reported to describe the temporal and 
spatial deposition of GAGs engineered cartilage with high accuracy (Obradovic et al. 
2000).  The mechanistic basis for their model lies in the hypothesis that the rate of GAG 
deposition depends on local oxygen concentration, as it was previously shown that 
GAG synthesis and tissue formation are sensitive to oxygen tension (Obradovic et al. 
1997; Obradovic et al. 1999).  The model equations are based fundamentally on 
conservation of mass, and describe the temporal changes in local oxygen concentration 
([O2]) and GAG concentration ([GAG]): 
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The first term on the right side of each equation describes the diffusion of each species 
through the construct.  The second term in Eq. 12 describes oxygen consumption by the 
cells, and is assumed to follow Michaelis-Menten kinetics where r is the cell density, Qm 
is the maximal oxygen consumption rate, and [O2]m is the oxygen concentration at half-
maximal oxygen consumption.  The second term in Eq. 13 describes GAG synthesis 
kinetics, and shows a first-order dependence on [O2], where [GAG]SS is the maximum 
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GAG concentration and k is the rate constant.  The authors note that the diffusion term 
in Eq. 13 is negligible throughout the construct (except at the surface) since DGAG is low.  
Considering this simplification, the GAG accumulation model appears similar to the 
model presented in this work, with an added term for oxygen-dependence; in the model 
from this work, the cell density and oxygen concentration parameters are assumed to 
be lumped into the time constant, t.  Notably, the authors’ sensitivity analysis indicate 
that adjustments of [GAG]SS and k generate the greatest deviation in predicted values 
from observed values of [GAG].  This suggests that despite the inclusion of several 
other adjustable parameters, including Qm, 2OD , DGAG, and [O2]m, their model is largely 
consistent with the accumulation model proposed in this work.  In addition, it indicates 
that the rate constant k (or time constant, t, from this work) describing GAG synthesis 
kinetics is influenced by factors besides O2 concentration.  Overall, the model proposed 
by Obradovic et al. is more powerful than the matrix accumulation model from this work, 
since it is capable of describing both the temporal and the spatial distributions of GAG in 
developing engineered cartilage.  When the first-order dependence on O2 concentration 
is eliminated through spatial-averaging, however, the GAG accumulation kinetics 
equation is consistent with the model presented in this work. 
LIMITATIONS OF THE PROPOSED MODELS 
In general, the accumulation model can describe the rates and extent to which 
extracellular matrix components accumulate in engineered constructs with low to 
moderate deviation.  The behavior of collagen and GAG accumulation in published 
reports and the data generated in this study is an exponential asymptotic increase with 
time.  It is difficult, however, to compare the least-squares estimates of the time 
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constant and the steady state matrix molecule contents between data sets.  First, the 
data are reported in several different units, and conversion to a common set of units 
requires data on construct volume, construct mass, or cell number that is not available 
in all reports.  In addition, variation in the best-fit parameters between data sets is often 
the effect of multiple, confounded differences in experimental materials and methods.  
For example, the best-fit time constant that describes collagen accumulation data by 
Ragan et al. is 25% higher than the time constant for collagen data by Beekman et al., 
and the best-fit steady state collagen concentration is 43% lower in Ragan et al.’s study.  
These apparently dramatic differences in matrix accumulation are the result of 
numerous potential factors, including cell seeding density, concentration of alginate, 
scaffold geometry, age of the cell source, and cell isolation procedure.  Both studies 
involve the in vitro culture of bovine articular chondrocytes seeded in an alginate 
scaffold, and the time-dependent biosynthesis pattern of the constructs is similar.  But, it 
is important to consider that the observed differences in rate and extent of collagen 
accumulation may be attributed to numerous factors, and the effects of these factors are 
lumped within the adjustable parameters of the matrix accumulation model. 
Another, less critical, limitation of the presented models is that they are not readily 
applicable to in vivo development of engineered tissue constructs.  This is important 
because one premise of this work is that models can be used to estimate the properties 
– and by implication, therapeutic potential – of implantable engineered tissues.  Rather 
than cultivate the constructs ex vivo under controlled conditions, some investigators 
have studied the development of the new tissue through subcutaneous implantation in 
immuno-deficient (“nude”) animals (Laitinen et al. 1992; Puelacher et al. 1994; 
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Puelacher et al. 1994; Cao et al. 1997; Britt and Park 1998; Arevalo-Silva et al. 2001).  
A potential benefit of this approach is that the construct can be supplied with physiologic 
quantities of nutrients, growth factors, and other regulatory molecules by nearby blood 
vessels.  In addition, observations can be made about the physiologic response to the 
constructs.  Implanting these constructs into the body introduces several new factors 
that may influence scaffold degradation and matrix accumulation.  For example, the 
immune-competent body’s foreign body response (leading to fibrotic encapsulation) 
may expose the construct to a continuously changing cellular and biochemical 
environment.  In addition, in vivo culture conditions may impose nonuniform stresses 
and strains from surrounding organs or structures on the scaffold and cells, which may 
influence the rate of growth or the organization of new tissue.  The presented models 
are not capable of predicting the effects of these factors, and the differences in cell-
scaffold behavior between in vivo and in vitro culture are unclear.  So, it is important to 
note that our models may be used to estimate the composition of what goes into the 
body, but may not be useful in predicting the compositional fate of constructs in vivo. 
FUTURE WORK 
The modeling work presented here is a preliminary step in the development of more 
complex models capable of describing and revealing the nuances of matrix 
accumulation and scaffold degradation in engineered constructs.  Investigation of the 
simplifying assumptions made in this study is a necessary next step. 
The independence of proteoglycan and collagen accumulation is a critical assumption in 
the ECM accumulation model.  The assumption is supported by experimental data 
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suggesting that chondrocytes turnover proteoglycans more rapidly than collagen; the 
half-life of proteoglycans in vitro is from days to weeks, whereas collagen is more stable 
and has a half life ranging from 300 days to years (Hay 1991; Boyle et al. 1995).  In 
addition, the synthetic pathways for proteoglycans and collagen are markedly different, 
and this is expected given their distinct molecular structures.  Some characteristics of 
the extracellular matrix structure and assembly process, however, indicate that the 
mechanisms regulating proteoglycan and collagen deposition may be coupled.  The two 
biopolymers form an interpenetrating network in which steric and electrochemical 
interactions between the individual GAG and collagen molecules provide the bulk 
properties necessary for transmitting and absorbing physiologic loads in vivo.  There is, 
presumably, some optimal ECM composition that balances the contributions of energy 
absorbing GAGs (and associated water) and reinforcing collagen.  In addition, the 
extracellular formation of collagen fibrils is thought to rely on the presence of 
proteoglycans, and aggregation of proteoglycans has been shown to occur in 
interterritorial spaces of the extracellular matrix (Mow and Ratcliffe 1997), indicating 
another potential level of interaction between ECM components.  These points of 
functional dependence between matrix components suggest that collagen accumulation 
may depend directly or indirectly on GAG content and vice versa. 
It has been shown that treating cartilage explants with collagenase stimulates 
proteoglycan synthesis (Lee et al. 1994).  It is unclear, however, whether collagen 
synthesis is influenced by depletion of matrix GAGs and whether engineered tissue 
would exhibit similar responses.  One way of evaluating these questions is to perform 
an experiment in which engineered cartilage is cultured in the presence of an enzyme 
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that digests either the newly formed proteoglycans or collagen, and the relative collagen 
or GAG synthesis rates are measured.  Conversely, constructs may be cultured in 
media supplemented with free collagen or GAGs.  A control for these experiments is 
engineered cartilage cultured without the digestive enzymes or supplemented media.  
These experiments would provide data about how the quantity of each matrix 
component influences the synthesis and turnover of the other matrix component.  An 
important aspect of the hypothesized dependence is the potential role of matrix 
molecule arrangement because chondrocytes may be sensitive not only to the 
composition of the surrounding matrix but also to its structure. 
Another assumption made in this preliminary study is that scaffold degradation and 
matrix accumulation are independent.  As discussed above, chondrocyte adhesion to 
substrates and neotissue in the pericellular spaces via surface proteins may modulate 
biosynthesis behavior, and it has been shown that surface chemistry (primarily 
hydrophilicity and polypeptide activation) influences cell adhesion to different polymeric 
scaffold materials (Ishaug-Riley et al. 1999; Pakalns et al. 1999).  However, the effects 
of time dependent drops in scaffold mass, molecular weight, and surface area on 
chondrocyte biosynthesis have not been investigated.  An experiment to assess the 
interaction between matrix deposition and scaffold degradation might involve seeding 
chondrocytes on scaffolds that have undergone various degrees of degradation and 
measuring the biosynthetic response, perhaps via radiolabeled sulfate and proline 
incorporation rates.  This experiment may be performed with a variety of scaffold 
geometries and cell seeding densities in order to obtain information on these factors as 
well.  Conversely, it is important to note that cell metabolism or neotissue formation may 
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Figure 25. Degradation kinetics for a lower porosity (73%) PLGA 
scaffold (Lu et al. 2000). 
 
contribute to scaffold degradation that is faster or slower than the degradation of an 
unseeded scaffold.   
SECOND-GENERATION MODELS 
The biosynthetic behavior of chondrocytes in an engineered tissue construct may be 
better modeled at the cell scale.  A second-generation model for extracellular matrix 
accumulation may be developed to predict the response of individual cells.  This 
modeling approach would be more useful in probing the regulatory mechanisms of ECM 
synthesis and turnover since the presented model inherently averages the responses of 
millions of cells.  Measuring and modeling the temporal changes in pericellular 
environmental parameters like pH, osmolarity, and fixed charge density may clarify the 
relative contributions of each to the behavior of single cells. 
 
 
 
 
 
The degradation of some polymeric scaffolds, including those with lower porosity and 
more hydrophobic surface chemistry, are not as well-described by the presented model.  
Deviation consistently arises at early degradation times when the model predicts an 
immediate drop in scaffold mass and the experimental data indicate a delay of days to 
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weeks before this drop occurs.  This behavior is marked by a sigmoidal mass decay 
pattern, as illustrated in Fig. 25.  
The plateau at early degradation times may be due to limited diffusion of water into the 
scaffold and degradation products from the scaffold.  Erosion requires uptake of water 
by the scaffold and mass loss requires diffusion of degradation products from the 
scaffold into the aqueous environment.  Low porosity, hydrophobic chemistry, and large 
geometries inhibit the transfer of water into, and diffusion of degradation products out of 
the scaffold.  Scaffolds with these characteristics exhibit an initial “induction” period in 
which water is slowly absorbed, hydrolysis begins and molecular weight drops, but 
degradation products are still too big to move out of the scaffold.  At the end of the 
induction period, the molecular weight of the degradation products has decreased 
sufficiently to allow for rapid diffusion into the media and scaffold mass loss is observed. 
It has been suggested that Prout-Tompkins (PT) kinetics may be used to describe the 
degradation behavior of poly lactide-co-glycolide (PLGA) beads (Dunne et al. 2000).  
The PT equation (14) uses adjustable parameters tmax and t, indicating the time to 
maximum rate of mass loss and the time constant, respectively: 
(14)    
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The PT equation has applications in drug delivery and other pharmacuetical 
applications (e.g., describing the hydrolysis of aspirin), though it was initially used to 
describe the thermal degradation of crystalline salts and was based on a nucleus 
branching mechanism (Prout and Tompkins 1944; Brown 1997; Brown and Glass 
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1999).  The equation yields a sigmoidal decay curve, but a mechanistic understanding 
of its use in the context of this study is required. 
Finally, a second-generation modeling scheme will include methods of predicting the 
mechanical properties of engineered constructs.  It has been shown previously that the 
shear modulus of chondrocyte-PGA constructs depends on biochemical composition 
and microstructure (Stading and Langer 1999).  Rarely, however, is a quantitative 
connection between construct composition and mechanical properties developed.  A 
preliminary approach to developing this correlation will involve applying a rule of 
mixtures to determine the elastic modulus.  Volumes of the scaffold and new tissue 
components will be found using the accumulation and degradation models ([Scaffold](t), 
[Collagen](t), and [GAG](t)) and the density of each constituent (rScaffold, rCollagen, and 
rGAG): 
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The porosity of the construct may be estimated from these volumes and the gross 
volume of the construct (V0) using the relationship: 
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For a structure with macroscopic porosity, like a cell-polymer tissue construct, the 
elastic modulus may be determined using the phenomenological relationship (Martin et 
al. 1998): 
(17)    kSolidStructure PEE )1( -=  
where k is an adjustable parameter.  The elastic modulus of the solid part of the 
structure, ESolid, is calculated by a volume-fraction-weighted (vTissue and vScaffold) addition 
of the moduli of the new tissue and the scaffold according to the two-phase Voigt model 
(Hashin and Shtrikman 1963): 
(18)    ScaffoldScaffoldTissueTissueSolid EvEvE +=  
The volume fractions are defined in the following way: 
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One simplifying assumption in this modeling scheme is that under applied stress, the 
scaffold and tissue components of the construct undergo equivalent deformation (Jones 
1999).  This may not be a reasonable assumption because the tissue and the polymeric 
scaffold are expected to have highly variable, spatially dependent viscoelastic 
properties.  To address this issue, phenomenological relationships describing the elastic 
properties of a composite as a function of the constituents will be investigated (Kohles 
and Martinez 2000).  Another significant simplification in this approach is the omission 
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of a fluid phase that is thought to contribute appreciably to the mechanical properties of 
native cartilage (Mow et al. 1980). 
CONCLUSIONS 
The three specific aims of this project were to 1) develop mathematical models for the 
description of construct matrix accumulation and scaffold degradation kinetics in 
engineered cartilage systems, 2) validate the models with previously published and 
experimental data, and 3) apply the models to experimental data.  The models were 
derived from hypothesized mechanisms and are relatively simple: two adjustable 
parameters in an increasing, asymptotic exponential function for the accumulation 
model, and one adjustable parameter in a decreasing exponential function for the 
degradation model. A rigorous literature search revealed several studies of engineered 
cartilage with data on GAG and collagen accumulation, as well as several studies of 
polyester scaffold degradation; these data sets were used to validate the form of our 
models.  In addition, a long-term cell-scaffold in vitro culture experiment yielded data for 
model validation.  The fit of the matrix accumulation model to both GAG and collagen 
data from the literature and our experiment was moderate to strong as judged by the 
coefficient of determination (R2), and the model described the behavior with reasonable 
accuracy as judged by the RMS deviation.  Finally, the models were applied in the 
estimation of total construct mass as a function of culture time.  This total mass model, 
an additive combination of the matrix accumulation and scaffold degradation models, 
predicted the observed evolution of construct mass well as judged by R2 and with 
reasonable accuracy as judged by RMS deviation. 
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This work represents one of the first published attempts to characterize the patterns of 
temporal changes in biochemical composition of developing, engineered cartilage.  It 
may be useful in the elucidation of mechanisms and factors contributing to the 
regulation of chondrocyte biosynthesis and scaffold degradation in in vitro culture 
systems.  These models may be useful in designing cell-scaffold constructs and the 
culture conditions necessary for the generation of tissue with specified properties.  In 
addition, these models may reduce the need for long-term culture experiments by 
reliably predicting long-term effects from data gathered in short-term studies.  
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